LADARVision Gets Panel Nod For LASIK Hyperopia Correction With Conditions

Laser-assisted in situ keratomileusis (LASIK) labeling for Autonomous Technologies Corp.' s LADARVision ophthalmic excimer laser system should highlight declining predictability of outcome in patients with a pre-operative manifest refractive spherical equivalance (MRSE) or uncorrected visual acuity (UCVA) greater than +/-4 diopters.